Indication
as adjunctive therapy in the treatment of seizures associated with Lennox-Gastaut syndrome in patients 1 years of age and older

Medicine details

Medicine name:
rufinamide (Inovelon)
SMC ID:
2146
Pharmaceutical company
Eisai Ltd
BNF chapter
Central nervous system
Submission type
Abbreviated submission
Status
Advice due date:
08 April 2019
SMC meeting date:
05 March 2019